Sermorelin Clinical Research: What the Evidence Actually Shows
Sermorelin is unusual in this series: it was once an FDA-approved drug. Here is what its real clinical history shows, and where the modern adult evidence falls short.
Pediatric approval
Real, FDA-approved
Older-adult studies
Small, positive
Modern adult trials
Thin
Mechanism
Well established
A once-approved drug, not a research chemical
Sermorelin is the first 29 amino acids of GHRH, which signals the pituitary to release its own growth hormone. It has a genuine approval history behind it.
The core point: sermorelin's pediatric evidence is real and led to FDA approval, which is more than almost any peptide here can say. The weak spot is the modern adult, anti-aging use, where the trial base is small and dated.
What has been studied, and how strong it is
Strong and approved in children, smaller and dated in adults.
-
Children, approved use
Growth hormone deficiency
Nightly sermorelin raised height velocity in children with GH deficiency, and most caught up in growth. This supported approval as Geref, a real, approved clinical use.
Prakash & Goa, BioDrugs 1999 (PMID 18031173)
-
Older adults
Small studies, modest effects
Nightly GHRH(1-29) for up to six months in healthy older adults raised IGF-1, increased lean mass and cut body fat modestly; sleep did not clearly improve. Suggestive, small, not definitive.
-
Adult review
A reasonable GH alternative
A review argued sermorelin is a reasonable alternative to HGH for adult GH insufficiency because the feedback loop stays intact, while noting the lack of large modern trials.
Walker, Clin Interv Aging 2006 (PMID 18046908)
-
The gap
Modern adult outcome trials
There are no large, modern controlled trials for the body-composition and anti-aging uses sermorelin is marketed for today. The pediatric approval does not transfer to those claims.
Genuine history, dated adult evidence
Sermorelin earns more credibility than most peptides here because it was actually approved and used as a medicine, and the pediatric data is real. Its discontinuation was a business decision, not a safety or efficacy failure, which is an important distinction.
The catch is that the modern marketing leans on adult, anti-aging benefits that rest on small, older studies rather than large controlled trials. The approval history is a real strength; it is just not evidence for every use the compound is now sold for.
Where sermorelin stands in the US
No brand sold today, but a legal compounding route.
No FDA-approved sermorelin product is currently sold; Geref was discontinued in 2008, and a 2013 FDA determination found it was not withdrawn for safety or effectiveness. Licensed 503A pharmacies can compound it by prescription. Research-grade sermorelin is not for human use. Full picture on the sermorelin profile.
Frequently asked questions
Has sermorelin been tested in humans?
Yes, more than most peptides here. Sermorelin was an FDA-approved drug (Geref) for children with growth hormone deficiency and was used as a diagnostic test of GH secretion, so it has a genuine clinical trial and approval history. There are also small studies in healthy older adults. What is thin is modern, large adult trials for the anti-aging and body-composition uses it is now marketed for.
What did the research show in children?
In pediatric growth hormone deficiency, nightly sermorelin raised height velocity and most children caught up in growth, which supported its approval as Geref. The effect was smaller than daily HGH, but it was a real, approved clinical use, which sets sermorelin apart from research-only peptides.
What did the studies in older adults show?
Small studies of nightly GHRH(1-29) in healthy older adults for up to six months raised IGF-1, increased lean mass and reduced body fat modestly. Sleep quality did not clearly improve. These are small studies, not large controlled trials, so they are suggestive rather than definitive.
If it worked, why is sermorelin not sold as Geref anymore?
The brand was discontinued in 2008 for business reasons, and a 2013 FDA determination found it was not withdrawn for safety or effectiveness. That is why licensed compounding pharmacies can prepare it: it was part of an approved drug not pulled for safety. It is a discontinuation story, not a failure story.
Is sermorelin FDA-approved today?
There is no FDA-approved sermorelin product currently sold; the Geref brand was discontinued in 2008. It is available in the US as a compounded prescription through licensed 503A pharmacies. Research-grade sermorelin sold as a chemical is not for human use.
What is missing from the evidence?
Large, modern, controlled adult trials for the goals sermorelin is marketed for now, body composition, recovery and anti-aging, rather than the pediatric approval data and small older-adult studies that exist. The approval history is real; the modern adult evidence base is thin.
Track your protocol with the evidence in view
Log nightly doses, IGF-1 and how you feel in one place, and keep expectations tied to the data. Free.
Sources
- Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-157. PMID 18031173
- Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clin Interv Aging. 2006;1(4):307-308. PMID 18046908
- Sermorelin approval (1997), discontinuation (2008) and the 2013 FDA determination that it was not withdrawn for safety or effectiveness. Wikipedia summary
This content is for informational purposes only and is not medical advice. No FDA-approved sermorelin product is sold today; the Geref brand was discontinued in 2008. It is available in the US as a compounded prescription. The modern adult, anti-aging uses rest on small, dated studies rather than large controlled trials. Research-grade sermorelin is not for human use. Always consult a qualified healthcare provider.